Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge

Rebecca Tempel, Xin He Lai, Lidia Crosa, Briana Kozlowicz, Fred Heffron

    Research output: Contribution to journalArticle

    83 Citations (Scopus)

    Abstract

    Francisella tularensis is the bacterial pathogen that causes tularemia in humans and a number of animals. To date, there is no approved vaccine for this widespread and life-threatening disease. The goal of this study was to identify F. tularensis mutants that can be used in the development of a live attenuated vaccine. We screened F. novicida transposon mutants to identify mutants that exhibited reduced growth in mouse macrophages, as these cells are the preferred host cells of Francisella and an essential component of the innate immune system. This approach yielded 16 F. novicida mutants that were 100-fold more attenuated for virulence in a mouse model than the wild-type parental strain. These mutants were then tested to determine their abilities to protect mice against challenge with high doses of wild-type bacteria. Five of the 16 attenuated mutants (with mutations corresponding to dsbB, FTT0742, pdpB, fumA, and carB in the F. tularensis SCHU S4 strain) provided mice with protection against challenge with high doses (>8 × 105 CFU) of wild-type F. novicida. We believe that these findings will be of use in the design of a vaccine against tularemia.

    Original languageEnglish (US)
    Pages (from-to)5095-5105
    Number of pages11
    JournalInfection and Immunity
    Volume74
    Issue number9
    DOIs
    StatePublished - Sep 2006

    Fingerprint

    Francisella
    Francisella tularensis
    Tularemia
    Vaccines
    Attenuated Vaccines
    Virulence
    Immune System
    Macrophages
    Bacteria
    Mutation
    Growth

    ASJC Scopus subject areas

    • Immunology

    Cite this

    Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. / Tempel, Rebecca; Lai, Xin He; Crosa, Lidia; Kozlowicz, Briana; Heffron, Fred.

    In: Infection and Immunity, Vol. 74, No. 9, 09.2006, p. 5095-5105.

    Research output: Contribution to journalArticle

    Tempel, Rebecca ; Lai, Xin He ; Crosa, Lidia ; Kozlowicz, Briana ; Heffron, Fred. / Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. In: Infection and Immunity. 2006 ; Vol. 74, No. 9. pp. 5095-5105.
    @article{825dc4c35d6044c2a889de0379190437,
    title = "Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge",
    abstract = "Francisella tularensis is the bacterial pathogen that causes tularemia in humans and a number of animals. To date, there is no approved vaccine for this widespread and life-threatening disease. The goal of this study was to identify F. tularensis mutants that can be used in the development of a live attenuated vaccine. We screened F. novicida transposon mutants to identify mutants that exhibited reduced growth in mouse macrophages, as these cells are the preferred host cells of Francisella and an essential component of the innate immune system. This approach yielded 16 F. novicida mutants that were 100-fold more attenuated for virulence in a mouse model than the wild-type parental strain. These mutants were then tested to determine their abilities to protect mice against challenge with high doses of wild-type bacteria. Five of the 16 attenuated mutants (with mutations corresponding to dsbB, FTT0742, pdpB, fumA, and carB in the F. tularensis SCHU S4 strain) provided mice with protection against challenge with high doses (>8 × 105 CFU) of wild-type F. novicida. We believe that these findings will be of use in the design of a vaccine against tularemia.",
    author = "Rebecca Tempel and Lai, {Xin He} and Lidia Crosa and Briana Kozlowicz and Fred Heffron",
    year = "2006",
    month = "9",
    doi = "10.1128/IAI.00598-06",
    language = "English (US)",
    volume = "74",
    pages = "5095--5105",
    journal = "Infection and Immunity",
    issn = "0019-9567",
    publisher = "American Society for Microbiology",
    number = "9",

    }

    TY - JOUR

    T1 - Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge

    AU - Tempel, Rebecca

    AU - Lai, Xin He

    AU - Crosa, Lidia

    AU - Kozlowicz, Briana

    AU - Heffron, Fred

    PY - 2006/9

    Y1 - 2006/9

    N2 - Francisella tularensis is the bacterial pathogen that causes tularemia in humans and a number of animals. To date, there is no approved vaccine for this widespread and life-threatening disease. The goal of this study was to identify F. tularensis mutants that can be used in the development of a live attenuated vaccine. We screened F. novicida transposon mutants to identify mutants that exhibited reduced growth in mouse macrophages, as these cells are the preferred host cells of Francisella and an essential component of the innate immune system. This approach yielded 16 F. novicida mutants that were 100-fold more attenuated for virulence in a mouse model than the wild-type parental strain. These mutants were then tested to determine their abilities to protect mice against challenge with high doses of wild-type bacteria. Five of the 16 attenuated mutants (with mutations corresponding to dsbB, FTT0742, pdpB, fumA, and carB in the F. tularensis SCHU S4 strain) provided mice with protection against challenge with high doses (>8 × 105 CFU) of wild-type F. novicida. We believe that these findings will be of use in the design of a vaccine against tularemia.

    AB - Francisella tularensis is the bacterial pathogen that causes tularemia in humans and a number of animals. To date, there is no approved vaccine for this widespread and life-threatening disease. The goal of this study was to identify F. tularensis mutants that can be used in the development of a live attenuated vaccine. We screened F. novicida transposon mutants to identify mutants that exhibited reduced growth in mouse macrophages, as these cells are the preferred host cells of Francisella and an essential component of the innate immune system. This approach yielded 16 F. novicida mutants that were 100-fold more attenuated for virulence in a mouse model than the wild-type parental strain. These mutants were then tested to determine their abilities to protect mice against challenge with high doses of wild-type bacteria. Five of the 16 attenuated mutants (with mutations corresponding to dsbB, FTT0742, pdpB, fumA, and carB in the F. tularensis SCHU S4 strain) provided mice with protection against challenge with high doses (>8 × 105 CFU) of wild-type F. novicida. We believe that these findings will be of use in the design of a vaccine against tularemia.

    UR - http://www.scopus.com/inward/record.url?scp=33748028835&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33748028835&partnerID=8YFLogxK

    U2 - 10.1128/IAI.00598-06

    DO - 10.1128/IAI.00598-06

    M3 - Article

    VL - 74

    SP - 5095

    EP - 5105

    JO - Infection and Immunity

    JF - Infection and Immunity

    SN - 0019-9567

    IS - 9

    ER -